AKYA - Income Statement - Akoya Biosciences, Inc.

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
REVENUE
Revenue	81.7	96.6	74.9	54.9	42.4	42.2
GROSS PROFIT
Cost Of Revenue	33.8	40.3	31.5	20.7	16.5	17.6
Gross Profit	47.9	56.3	43.4	34.2	25.9	24.7
OPERATING INCOME
Operating Expenses	94.6	114.0	109.6	71.4	37.4	38.2
Selling, General and Administrative Expenses	69.3	82.4	79.7	51.0	24.0	26.4
Research and Development Expenses	19.7	21.9	23.2	15.7	9.6	8.8
Operating Income	(46.7)	(57.7)	(66.2)	(37.2)	(11.5)	(13.5)
PRE-TAX INCOME
Interest Income Expense	10.4	8.8	4.6	3.1	2.7	1.9
Total Other Income	(8.5)	(5.6)	(4.4)	(3.8)	(4.7)	(2.3)
Pre-Tax Income	(9.6)	(17.3)	(20.0)	(56.4)	(6.9)	(5.2)	(10.5)	(11.5)	(6.5)	(2.0)	32.8 K	1.29 K	22.7 K	31.4 K	35.9 K	55.6 K	(0.1)	0.8	(0.3)	82.4 K	(0.2)	(0.5)	12.2 K	(0.2)	0.4	0.4	(5.8)	(4.7)	(25.1)	(3.2)	0
NET INCOME
Tax Provision	8.93 K	28.9 K	(1.5)	(7.5)	(0.5)	0.4	6.3	(2.4)	(3.7)	(0.1)	833	1.45 K	1.93 K	1.98 K	3.57 K	2.98 K	4.84 K	(0.6)	4.8 K	874	400	5.42 K	6.1 K	2.86 K	10 K	6.5 K	38.2 K	60.7 K	0.3	100 K	100 K
Net Income	(9.6)	17.3 K	(18.5)	(49.0)	(6.4)	(5.6)	(16.9)	(9.1)	(2.8)	(1.9)	33.6 K	161	24.6 K	33.4 K	39.4 K	58.5 K	(0.1)	0.8	(0.4)	81.5 K	(0.2)	(0.5)	18.3 K	(0.2)	0.4	0.4	(5.8)	(4.7)	(25.4)	(3.2)	(1.2)
EPS	19	8.09	12.8	104	55.5	212	3.55 K	3.03 K	1.06 K	856	192	1.18	180	244	540	802	1.97 K	11.1 K	6.41 K	1.48 K	2.97 K	9.35 K	345	4.53 K	7.21 K	6.82 K	(0.2)	(0.2)	(1.2)	(0.2)	70.6 K

Free